Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
Clinical trial NCT05025423 · TERMINATED
Trial details
- NCT number
- NCT05025423
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2025-05-14
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.